Otc Nasal Spray Seemed to Cut Covid Infections by 67% in Mid-Sized Trial
Posted4 months ago
arstechnica.comResearchstory
calmpositive
Debate
0/100
Covid-19Nasal SprayOtc Treatment
Key topics
Covid-19
Nasal Spray
Otc Treatment
A mid-sized trial found that an OTC nasal spray reduced Covid infections by 67%, but the lack of comments suggests the community is waiting for more information or validation.
Snapshot generated from the HN discussion
Discussion Activity
No activity data yet
We're still syncing comments from Hacker News.
Generating AI Summary...
Analyzing up to 500 comments to identify key contributors and discussion patterns
ID: 45110803Type: storyLast synced: 11/20/2025, 11:47:20 AM
Want the full context?
Jump to the original sources
Read the primary article or dive into the live Hacker News thread when you're ready.
Discussion hasn't started yet.